The most frequent structural variation of KMT2A in AML and acute lymphoblastic leukemia (ALL) is KMT2A-rearrangement (KMT2A-r), which is present in 10% of hematologic malignancies. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.